Skip to main content

Raul Aguilar Lopez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Raul Aguilar Lopez

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Toxicitat cardiovascular en el càncer de mama HER 2-positiu precoç: desde l'avaluació del risc fins a la prevenció

IP: Ignacio Ferreira González
Collaborators: José Antonio Barrabés Riu, José Raul Herance Camacho, Gerard Oristrell Santamaria, Javier Limeres Freire, Raul Aguilar Lopez, Filipa Xavier De Carvalho Negrao Valente, Sofía Vila-Sanjuán Zamora
Funding agency: Fundació La Marató de TV3
Funding: 198125
Reference: 202311-10
Duration: 11/03/2024 - 10/03/2027

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Personal Investigador para Grupo Cardiovascular, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Personal Investigador para Grupo Cardiovascular, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Personal Investigador para Grupo Cardiovascular, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

Impact of an exercise-based rehabilitation program in patients with Marfan syndrome on physical, psychological and cardiovascular health

IP: Gisela Teixido Tura
Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez, Clara Badia Molins
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI21/00448
Duration: 01/01/2022 - 31/12/2024

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

María de los Ángeles Rodríguez Sánchez

María de los Ángeles Rodríguez Sánchez

Administration and Management
Childhood Cancer and Blood Disorders
Read more
Pedro Alejandro Gil Millán

Pedro Alejandro Gil Millán

Predoctoral researcher
Diabetes and Metabolism
Read more
Javier Lopez-Ibañez Infante

Javier Lopez-Ibañez Infante

Tècnic/a Superior Recerca
Statistics and Bioinformatics Unit (UEB)
Preclinical Core Facilities
External Strategy Directorate
Read more
Clàudia Carrera Muñoz

Clàudia Carrera Muñoz

Research technician
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.